2013 EACPT Geneva Congress Symposia: Innovative medicine initiative

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications

Symposium on Innovative medicine initiative

The Innovative Medicines Initiative (IMI, www.imi.europa.eu) is the world’s largest public-private partnership in health. IMI is improving the environment for pharmaceutical innovation in Europe by creating networks of industrial and academic experts in collaborative research projects. The EU contributes €1 billion to IMI’s research programme; this is matched by in kind contributions of €1 billion from members of the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI currently supports 37 projects, many of which are producing impressive results. The projects are speeding up the development of better and safer medicines for patients by addressing major bottlenecks in drug development.

Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org